Andrea L. Merrill

Andrea L. Merrill

Auto-generated profile, based on publicly available information

Andrea L. Merrill

Massachusetts General Hospital

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in Archives of Surgery
Verified
Journal Article
Closed access
PDF file
SGSabha Ganai
Sabha Ganai
KLK. Francis Lee
K. Francis Lee
AMAndrea Merrill
Andrea Merrill
MLMaggie H. Lee
Maggie H. Lee
SBSandra Bellantonio
Sandra Bellantonio
PLPeter Lindenauer
Peter Lindenauer
Research from JAMA Surgery — Adverse Outcomes of Geriatric Patients Undergoing Abdominal Surgery Who Are at High Risk for Delirium

21 October 2008 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
AMAndrea Merrill
Andrea Merrill
KGKara Guzman
Kara Guzman
SMSuzanne L. Miller
Suzanne L. Miller

9 June 2018 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
BSBarbara L. Smith
Barbara L. Smith
MGMichele A. Gadd
Michele A. Gadd
CLConor R. Lanahan
Conor R. Lanahan
URUpahvan Rai
Upahvan Rai
RTRong Tang
Rong Tang
MSMichelle C. Specht
Michelle C. Specht

1 February 2012 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
AMAndrea Merrill
Andrea Merrill
FMFrederick Millham
Frederick Millham
Patients with inflammatory bowel disease (IBD) are at increased risk for thromboembolic events, especially deep vein thrombosis (DVT) and pulmonary embolism (PE). This association was first described in 1936 by Bargen and Barker,1 who described 18 patients with thromboembolic disease (predominantly venous) in more than 1000 patients treated for IBD at Mayo Clinic. Recent publications suggest that patients with IBD have increased risk of venous thromboembolism varying from as low as 1.5 times that of nonaffected patients2,3 to as high as 4.7-fold for patients with Crohn disease in a population-based cohort study.4 Moreover, patients with IBD who have PE appear to have increased risk of death compared with others.2,5 Despite these findings, standard DVT and PE prophylaxis guidelines do not recommend enhanced prophylaxis for patients with IBD.6-8 Recent data suggest that patients with IBD who require surgery are at very high risk for DVT. Scarpa et al9 have reported that, compared with patients with cancer undergoing colon resections, patients with ulcerative colitis have an odds ratio (OR) of 7.4 for having postoperative DVT.

23 July 2015 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
RTRong Tang
Rong Tang
SCSuzanne B. Coopey
Suzanne B. Coopey
ACAmy S. Colwell
Amy S. Colwell
MSMichelle C. Specht
Michelle C. Specht
MGMichele A. Gadd
Michele A. Gadd
BSBarbara L. Smith
Barbara L. Smith

1 June 2016 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
RTRong Tang
Rong Tang
SCSuzanne B. Coopey
Suzanne B. Coopey
AMAndrea L. Merrill
Andrea L. Merrill
URUpahvan Rai
Upahvan Rai
MSMichelle C. Specht
Michelle C. Specht
BSBarbara L. Smith
Barbara L. Smith
BACKGROUND: When a nipple margin of a nipple-sparing mastectomy (NSM) contains malignancy, current practice includes removal of the nipple or nipple areola complex (NAC). We evaluated rates and trends of positive nipple margins, subsequent management, and oncologic outcomes. STUDY DESIGN: A retrospective chart review of all NSM at our institution from 2007 to 2014 was performed. A descriptive analysis was performed of patients with positive nipple/subareolar margins. RESULTS: Among 1,326 NSM, 43 of 642 (6.7%) therapeutic and 3 of 684 (0.4%) prophylactic NSM had positive nipple margins. Nipple or NAC excision was performed for 39 of 46 (85%) positive nipple margins: 20 of 39 (51%) had nipple only and 19 of 39 (49%) had the entire NAC excised. Practice evolved to remove only the nipple and retain the areola for positive nipple margins: in 2007 to 2011, 7 of 17 (41%) underwent nipple-only excision compared with 14 of 22 (64%) in 2012 to 2014. Among 39 excised nipples/NAC, 28 (72%) contained no residual malignancy, while 8 contained ductal carcinoma in situ (DCIS), 2 had invasive lobular carcinoma, and 1 had invasive ductal carcinoma. With experience, rates of positive nipple margins for therapeutic NSM decreased from 11% (17 of 160) in 2007 to 2011 to 5.4% (26 of 482) in 2012 to 2014 (p < 0.05). At 36 month median follow-up, there were no recurrences in the nipple/NAC. CONCLUSIONS: Early results suggest that excision of the nipple with retention of the areola is a safe approach for management of a positive nipple margin after NSM. With experience, low rates of positive nipple margins are possible in therapeutic NSM. Overall risk of nipple/NAC recurrence after NSM remains extremely low.